Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000842023-10-000026

Options or other derivatives

  • VP Hematology Operations acquired 1,281 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

VERONNEAU MARCEL · VP Hematology Operations

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2010-07-30 Grant or award : show line 1 in the form Employee Stock Option +1,281 $58.40 2017-07-29 1,281 1,281 D
Loading xslF345X03/primary_doc.xml…